138 related articles for article (PubMed ID: 38166779)
1. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants.
Zhao S; Miao M; Wang Q; Zhao H; Yang H; Wang X
BMC Cancer; 2024 Jan; 24(1):30. PubMed ID: 38166779
[TBL] [Abstract][Full Text] [Related]
2. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
Ludmir EB; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Mandel JJ; Lin SH; Smith BD; Smith GL; VanderWalde NA; Minsky BD; Koong AC; Stinchcombe TE; Jagsi R; Gomez DR; Thomas CR; Fuller CD
JAMA Oncol; 2019 Dec; 5(12):1769-1773. PubMed ID: 31158272
[TBL] [Abstract][Full Text] [Related]
3. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
7. Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
Schulkes KJ; Nguyen C; van den Bos F; van Elden LJ; Hamaker ME
Lung; 2016 Dec; 194(6):967-974. PubMed ID: 27650509
[TBL] [Abstract][Full Text] [Related]
8. Older cancer patients in cancer clinical trials are underrepresented. Systematic literature review of almost 5000 meta- and pooled analyses of phase III randomized trials of survival from breast, prostate and lung cancer.
Dunn C; Wilson A; Sitas F
Cancer Epidemiol; 2017 Dec; 51():113-117. PubMed ID: 29126091
[TBL] [Abstract][Full Text] [Related]
9. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
[TBL] [Abstract][Full Text] [Related]
10. Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.
Riaz IB; Islam M; Ikram W; Naqvi SAA; Maqsood H; Saleem Y; Riaz A; Ravi P; Wang Z; Hussain SA; Warner JL; Odedina FT; Duma N; Singh P; Kehl KL; Kamran SC; Murad MH; Landman A; Van Allen E; Bryce AH
JAMA Oncol; 2023 Feb; 9(2):180-187. PubMed ID: 36416812
[TBL] [Abstract][Full Text] [Related]
11. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
[TBL] [Abstract][Full Text] [Related]
12. The effect of prior cancer on non-small cell lung cancer trial eligibility.
Herman M; Liu Z; Shepherd FA; Leighl N; Liu G; Bradbury PA
Cancer Med; 2021 Jul; 10(14):4814-4822. PubMed ID: 34145985
[TBL] [Abstract][Full Text] [Related]
13. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
[TBL] [Abstract][Full Text] [Related]
14. Disparities in Breast, Lung, and Cervical Cancer Trials Worldwide.
Ramaswami R; Paulino E; Barrichello A; Nogueira-Rodrigues A; Bukowski A; St Louis J; Goss PE
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241268
[TBL] [Abstract][Full Text] [Related]
15. Cancer trial enrollment after state-mandated reimbursement.
Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
[TBL] [Abstract][Full Text] [Related]
16. Disparities in phase 1 cancer clinical trial enrollment.
Perni S; Moy B; Nipp RD
Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
[TBL] [Abstract][Full Text] [Related]
17. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
18. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
